Article

Broadening participation in clinical trials: A win for all

Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation

Maimah Karmo: Surviving, fighting, winning

The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they d...

Automation is key in cell and gene therapy manufacturing

Although the list of cell and gene therapies is growing, prices remain high. Now developers are working on a road map to streamline producti...

From complexity to clarity in cell and gene therapy

Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about t...

Survey results: Accelerating digital transformation during COVID-19

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations

Clinical

Latest Articles

Broadening participation in clinical trials: A win for all

Joseph Constance, (Jan 6, 2021)

Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation
Maimah Karmo: Surviving, fighting, winning

Andrew Stone, (Nov 26, 2020)

The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they deserve in trials and beyond
Automation is key in cell and gene therapy manufacturing

Andrew Stone, (Oct 30, 2020)

Although the list of cell and gene therapies is growing, prices remain high. Now developers are working on a road map to streamline production and drop costs
From complexity to clarity in cell and gene therapy

Andrew Stone, (Sep 16, 2020)

Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Survey results: Accelerating digital transformation during COVID-19

Nicola Davies, (Sep 4, 2020)

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Breaking new ground in healthcare data

Andrew Stone, (Apr 16, 2020)

Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, faster insights
Building a bridge to a COVID-19 vaccine

Andrew Stone, (Apr 15, 2020)

Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual
Moving remote: the post-pandemic clinical trial

Lucy Fulford, (Apr 3, 2020)

Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over
Imagining the ‘Digitome’

Andrew Stone, (Feb 28, 2020)

Dramatic advances in human health beckon if pharma can help build ‘the Digitome’, a vast data commons
RWE: A new hope for rare disease

Lucy Fulford, (Jan 30, 2020)

RWE shows great promise in helping accelerate treatments for rare disease